Valeant Company Profile

« Back to Dashboard

What is the competitive landscape for VALEANT

VALEANT has sixty-seven approved drugs.

There are six US patents protecting VALEANT drugs.

Summary for Valeant

US Patents:	6
Tradenames:	55
Ingredients:	45
NDAs:	67
Patent Litigation for Valeant:	See patent lawsuits for Valeant

Drugs and US Patents for Valeant

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Valeant Pharm Intl	MEPROBAMATE	meprobamate	TABLET;ORAL	015139-006	Approved Prior to Jan 1, 1982		DISCN	No	No
Valeant Pharms North	DERMATOP	prednicarbate	OINTMENT;TOPICAL	019568-001	Sep 23, 1991		DISCN	Yes	No
Valeant Pharm Intl	DALMANE	flurazepam hydrochloride	CAPSULE;ORAL	016721-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Valeant Luxembourg	GRIFULVIN V	griseofulvin, microsize	TABLET;ORAL	062279-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Valeant Pharms North	SECONAL SODIUM	secobarbital sodium	CAPSULE;ORAL	086101-002	Oct 3, 1983		DISCN	No	No

Expired US Patents for Valeant

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Pharm Intl	LIBRIUM	chlordiazepoxide hydrochloride	CAPSULE;ORAL	012249-001	Approved Prior to Jan 1, 1982	4,316,897
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995	4,423,041
Valeant Pharms	ULTRAM ER	tramadol hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021692-002	Sep 8, 2005	6,254,887
Valeant Pharm Intl	PERMAX	pergolide mesylate	TABLET;ORAL	019385-003	Dec 30, 1988	4,180,582
Valeant Pharms North	RENOVA	tretinoin	CREAM;TOPICAL	019963-001	Dec 29, 1995	RE36068

Paragraph IV (Patent) Challenges for VALEANT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Tablets	200 mg		2007-03-28
	Tablets	1.1 g		2013-11-05
	Extended-release Tablets	100 mg		2007-01-08
	Extended-release Tablets	300 mg		2007-09-25

International Patents for Valeant Drugs

Country	Patent Number	Estimated Expiration
Brazil	PI0717859
European Patent Office	1931354
New Zealand	603744
Canada	2797560
Japan	2009506067

Supplementary Protection Certificates for Valeant Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1539166	2013/055	Ireland		PRODUCT NAME: THE COMBINATION OF: (A) DEXTROMETHORPHAN OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRECURSOR OR DERIVATIVE THEREOF, E.G. DEXTROMETHORPHAN HYDROBROMIDE AND IN PARTICULAR DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE; AND (B) QUINIDINE OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRECURSOR OR DERIVATIVE THEREOF, E.G. QUINIDINE SULPHATE AND IN PARTICULAR QUINIDINE SULPHATE DIHYDRATE, PROTECTED BY THE BASIC PATENT; REGISTRATION NO/DATE: EU/1/13/833 20130624
0137963	97C0042	Belgium		PRODUCT NAME: 2-(2-BENZOYL-SUBSTITUE)-1,3-CYCLOHEXANE-DIONES; REGISTRATION NO/DATE: 8452/B 19930121
2488169	C202330042	Spain		PRODUCT NAME: COCRISTAL DE TRAMADOL, OPCIONALMENTE EN FORMA DE UNA SAL FISIOLOGICAMENTE ACEPTABLE, Y CELECOXIB; NATIONAL AUTHORISATION NUMBER: 89051; DATE OF AUTHORISATION: 20230925; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 89051; DATE OF FIRST AUTHORISATION IN EEA: 20230925
1458369	C01458369/01	Switzerland		PRODUCT NAME: ADAPALENUM + BENZOYLIS PEROXIDUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 58460 19.05.2009
0566709	C300152	Netherlands		PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Vale
• Valeant
• Valeant Bermuda
• Valeant Intl
• Valeant Luxembourg